Literature DB >> 17605921

[Strategies to resolve the problem of lack of keratoplasty materials in China].

Ming-Chang Zhang1.   

Abstract

Keratoplasty is the major option for the treatment of blindness due to corneal diseases. Lack of donors' cornea for keratoplasty remains the major obstacle for the treatment of blindness due to corneal diseases in China. In order to obtain sufficient cornea available for transplantation, it is necessary to have a comprehensive approach improving the awareness of the public by strengthening the publicity, encouraging people to participate in the donation of cornea, appealing for the establishment of transplantation laws, establishing a legal and transparent organ donation system as well as to establish standardized eye banks. In addition, more attention should be paid on the selection of suitable surgery approaches and indications of keratoplasty, the improvement of peri-operation management, to utilize any possible way to improve the cornea diseases-induced blindness patients' sight, to improve the successful rate of transplantation as well as to reduce the waste of corneal grafts. At the meantime, it is necessary to study and to develop new corneal materials, especially by tissue engineering methods, to relieve the problem of deficiency of cornea grafts in China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605921

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  Limitations of Keratoplasty in China: A Survey Analysis.

Authors:  Jiaxu Hong; Weiyun Shi; Zuguo Liu; Roberto Pineda; Xinhan Cui; Xinghuai Sun; Jianjiang Xu
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

2.  Specific demographic factors could predict deceased potential cornea donors: A retrospective study from Beijing Tongren Hospital Eye Bank.

Authors:  Yang Liu; Yingnan Zhang; Jing Zhang; Jin Yu; Qingfeng Liang; Zhiqiang Pan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.